95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.59%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-16.62%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-15.52%
Negative EBIT growth while OR is at 23.56%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.52%
Negative operating income growth while OR is at 23.56%. Joel Greenblatt would press for urgent turnaround measures.
-18.77%
Negative net income growth while OR stands at 112.16%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-18.92%
Negative EPS growth while OR is at 111.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.92%
Negative diluted EPS growth while OR is at 111.38%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.05%
Share reduction more than 1.5x OR's 2.40%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.11%
Diluted share count expanding well above OR's 0.19%. Michael Burry would fear significant dilution to existing owners' stakes.
-44.76%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-6.99%
Negative OCF growth while OR is at 32.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
31.55%
FCF growth 75-90% of OR's 36.11%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
13.95%
10Y CAGR of 13.95% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
12.85%
5Y revenue/share CAGR under 50% of OR's 80.72%. Michael Burry would suspect a significant competitive gap or product weakness.
42.63%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-5.57%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
21.90%
Below 50% of OR's 74.06%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
82.91%
3Y OCF/share CAGR similar to OR's 85.25%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
-21.60%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
59.10%
Positive 5Y CAGR while OR is negative. John Neff might view this as a strong mid-term relative advantage.
290.73%
Positive short-term CAGR while OR is negative. John Neff would see a clear advantage in near-term profit trajectory.
86.13%
Equity/share CAGR of 86.13% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
18.37%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
14.03%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
323.53%
Dividend/share CAGR of 323.53% while OR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
190.02%
5Y dividend/share CAGR above 1.5x OR's 34.59%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.46%
3Y dividend/share CAGR above 1.5x OR's 1.13%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-24.73%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
280.32%
We show growth while OR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.09%
Positive asset growth while OR is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.97%
Positive BV/share change while OR is negative. John Neff sees a clear edge over a competitor losing equity.
-7.67%
We’re deleveraging while OR stands at 0.46%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-36.65%
We cut SG&A while OR invests at 23.86%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.